MOG and Alzheimer disease: No significant difference was seen in the mRS score at the worst condition among the MOG-AD, anti-NMDAR encephalitis, and MNOS groups, but there was a significant difference in second-line treatment, admission to the ICU, and length of in-hospital stay among the three groups (p < 0.05).